Jörg Scheidle
Directeur Général chez Luye Pharma (Germany) GmbH
Postes actifs de Jörg Scheidle
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Luye Pharma AG
 Luye Pharma AG Pharmaceuticals: MajorHealth Technology Luye Pharma AG engages in the development and manufacture of pharmaceutical products. It specializes in transdermal therapeutic systems as well as biodegradable, subcutaneous implants. The company is headquartered in Miesbach, Germany. | Directeur/Membre du Conseil | - | - |
Luye Pharma (Germany) GmbH
 Luye Pharma (Germany) GmbH MiscellaneousMiscellaneous Luye Pharma (Germany) GmbH engages in the acquisition, holding, management, and sale of participating interests in companies. It also provides remunerated and related services. The company was founded on April 20, 2016 and is headquartered in Miesbach, Germany. | Directeur Général | - | - |
Historique de carrière de Jörg Scheidle
Anciens postes connus de Jörg Scheidle
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Immatics Biotechnologies GmbH
 Immatics Biotechnologies GmbH Pharmaceuticals: MajorHealth Technology Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany. | Directeur Financier/CFO | - | - |
Formation de Jörg Scheidle
| University of Dayton | Masters Business Admin |
Statistiques
Internationale
| Allemagne | 4 |
| Etats-Unis | 2 |
Opérationnelle
| Director of Finance/CFO | 1 |
| Masters Business Admin | 1 |
| Director/Board Member | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
| Miscellaneous | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Immatics Biotechnologies GmbH
Immatics Biotechnologies GmbH Pharmaceuticals: MajorHealth Technology Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany. | Health Technology |
Luye Pharma AG
Luye Pharma AG Pharmaceuticals: MajorHealth Technology Luye Pharma AG engages in the development and manufacture of pharmaceutical products. It specializes in transdermal therapeutic systems as well as biodegradable, subcutaneous implants. The company is headquartered in Miesbach, Germany. | Health Technology |
Luye Pharma (Germany) GmbH
Luye Pharma (Germany) GmbH MiscellaneousMiscellaneous Luye Pharma (Germany) GmbH engages in the acquisition, holding, management, and sale of participating interests in companies. It also provides remunerated and related services. The company was founded on April 20, 2016 and is headquartered in Miesbach, Germany. | Miscellaneous |
- Bourse
- Insiders
- Jörg Scheidle
- Expérience
